Kymera Therapeutics (KYMR) Other Non Operating Income (2019 - 2026)

Kymera Therapeutics (KYMR) has 8 years of Other Non Operating Income data on file, last reported at $14.9 million in Q1 2026.

• Other Non Operating Income for Q1 2026 came in at $14.9 million, up 67.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $44.3 million (up 18.06% YoY), and the FY2025 annual result was $38.4 million, up 1.7% from the prior year.
• Other Non Operating Income improved to $14.9 million in Q1 2026 per KYMR's latest filing, from $11.0 million in the prior quarter.
• Over five years, Other Non Operating Income peaked at $14.9 million in Q1 2026 and troughed at $290000.0 in Q1 2022.
• A 5-year average of $6.8 million and a median of $8.1 million in 2025 frame the typical range for Other Non Operating Income.
• The sharpest annual moves came in 2022 and 2025: Other Non Operating Income jumped 12650.0% in 2022, then retreated 9.78% in 2025.
• A 5-year view of Other Non Operating Income shows it stood at $3.8 million in 2022, then surged by 36.52% to $5.1 million in 2023, then jumped by 94.61% to $10.0 million in 2024, then increased by 10.02% to $11.0 million in 2025, then surged by 35.57% to $14.9 million in 2026.
• Business Quant data shows KYMR's Other Non Operating Income at $14.9 million in Q1 2026, $11.0 million in Q4 2025, and $10.3 million in Q3 2025.